xu-wei

Keywords

🔗 severe acute (1373) 🔗 cytopathic effect (91) 🔗 respiratory syndrome-associated (90) 🔗 immune response (314) 🔗 antibody responses (58) 🔗 respiratory syndrome (2004) 🔗 acute respiratory (1734) 🔗 syndrome-associated coronavirus (88) 🔗 () 🔗 clinical characteristics (105) 🔗 imported cases (21) 🔗 pneumonia (602) 🔗 nucleic acid (139) 🔗 syndrome coronavirus (1074) 🔗 spike protein (353) 🔗 six-helix bundle (19) 🔗 high mortality (78) 🔗 cell-cell fusion (34) 🔗 public health (392) 🔗 amino acid (454) 🔗 human coronavirus (623) 🔗 crystal structure (114) 🔗 membrane fusion (105) 🔗 highly pathogenic (100)

Articles (8)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection.
👤 Liu, Zezhong 👤 Xia, Shuai 👤 Wang, Xinling 👤 Lan, Qiaoshuai 👤 Xu, Wei 👤 Wang, Qian 👤 Jiang, Shibo 👤 Lu, Lu ⏰ 2020 📚 Virol Sin
A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro
👤 Wang, Xiaohua 👤 Xu, Wei 👤 Tong, Deyan 👤 Ni, Jing 👤 Gao, Haifeng 👤 Wang, Ying 👤 Chu, Yiwei 👤 Li, Pingping 👤 Yang, Xiaoming 👤 Xiong, Sidong ⏰ 2008 📚 Immunology Letters
SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.
👤 Wang, Xinling 👤 Xu, Wei 👤 Hu, Gaowei 👤 Xia, Shuai 👤 Sun, Zhiping 👤 Liu, Zezhong 👤 Xie, Youhua 👤 Zhang, Rong 👤 Jiang, Shibo 👤 Lu, Lu ⏰ 2020 📚 Cell Mol Immunol
Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study.
👤 Wu, Jian 👤 Liu, Jun 👤 Zhao, Xinguo 👤 Liu, Chengyuan 👤 Wang, Wei 👤 Wang, Dawei 👤 Xu, Wei 👤 Zhang, Chunyu 👤 Yu, Jiong 👤 Jiang, Bin 👤 Cao, Hongcui 👤 Li, Lanjuan ⏰ 2020 📚 Clin Infect Dis
Potent MERS-CoV fusion inhibitory peptides identified from HR2 domain in spike protein of bat coronavirus HKU4
👤 Xia, Shuai 👤 Lan, Qiaoshuai 👤 Pu, Jing 👤 Wang, Cong 👤 Liu, Zezhong 👤 Xu, Wei 👤 Wang, Qian 👤 Liu, Huan 👤 Jiang, Shibo 👤 Lu, Lu ⏰ 2019 📚 Viruses
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
👤 Xia, Shuai 👤 Liu, Meiqin 👤 Wang, Chao 👤 Xu, Wei 👤 Lan, Qiaoshuai 👤 Feng, Siliang 👤 Qi, Feifei 👤 Bao, Linlin 👤 Du, Lanying 👤 Liu, Shuwen 👤 Qin, Chuan 👤 Sun, Fei 👤 Shi, Zhengli 👤 Zhu, Yun 👤 Jiang, Shibo 👤 Lu, Lu ⏰ 2020 📚 Cell Res
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
👤 Xia, Shuai 👤 Yan, Lei 👤 Xu, Wei 👤 Agrawal, Anurodh Shankar 👤 Algaissi, Abdullah 👤 Tseng, Chien Te K. 👤 Wang, Qian 👤 Du, Lanying 👤 Tan, Wenjie 👤 Wilson, Ian A. 👤 Jiang, Shibo 👤 Yang, Bei 👤 Lu, Lu ⏰ 2019 📚 Science Advances
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.
👤 Xia, Shuai 👤 Zhu, Yun 👤 Liu, Meiqin 👤 Lan, Qiaoshuai 👤 Xu, Wei 👤 Wu, Yanling 👤 Ying, Tianlei 👤 Liu, Shuwen 👤 Shi, Zhengli 👤 Jiang, Shibo 👤 Lu, Lu ⏰ 2020 📚 Cell Mol Immunol